Endothelial recovery: the next target in restenosis prevention

Circulation. 2003 Jun 3;107(21):2635-7. doi: 10.1161/01.CIR.0000071083.31270.C3.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Angioplasty, Balloon, Coronary / adverse effects
  • Animals
  • Antineoplastic Agents / administration & dosage
  • Cell Division / drug effects
  • Clinical Trials, Phase II as Topic
  • Coronary Restenosis / prevention & control*
  • Endothelial Growth Factors / administration & dosage*
  • Endothelial Growth Factors / biosynthesis
  • Endothelial Growth Factors / genetics
  • Endothelium, Vascular / drug effects
  • Endothelium, Vascular / metabolism*
  • Feasibility Studies
  • Genetic Therapy* / methods
  • Humans
  • Intercellular Signaling Peptides and Proteins / administration & dosage*
  • Intercellular Signaling Peptides and Proteins / biosynthesis
  • Intercellular Signaling Peptides and Proteins / genetics
  • Lymphokines / administration & dosage*
  • Lymphokines / biosynthesis
  • Lymphokines / genetics
  • Muscle, Smooth, Vascular / drug effects
  • Muscle, Smooth, Vascular / physiopathology
  • Pilot Projects
  • Stents / adverse effects
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factors

Substances

  • Antineoplastic Agents
  • Endothelial Growth Factors
  • Intercellular Signaling Peptides and Proteins
  • Lymphokines
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factors